Basics |
ADiTx Therapeutics, Inc.
|
IPO Date: |
June 30, 2020 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$3.07M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.22 | 5.98%
|
Avg Daily Range (30 D): |
$0.07 | 4.25%
|
Avg Daily Range (90 D): |
$0.19 | 7.49%
|
Institutional Daily Volume |
Avg Daily Volume: |
5.91M |
Avg Daily Volume (30 D): |
.1M |
Avg Daily Volume (90 D): |
47.21M |
Trade Size |
Avg Trade Size (Sh.): |
761 |
Avg Trade Size (Sh.) (30 D): |
172 |
Avg Trade Size (Sh.) (90 D): |
1,537 |
Institutional Trades |
Total Inst.Trades: |
23 |
Avg Inst. Trade: |
$.7M |
Avg Inst. Trade (30 D): |
$.51M |
Avg Inst. Trade (90 D): |
$.57M |
Avg Inst. Trade Volume: |
.01M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$.99M |
Avg Closing Trade (30 D): |
$M |
Avg Closing Trade (90 D): |
$M |
Avg Closing Volume: |
K |
|
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$88368.8
|
$-8.12
|
|
Diluted EPS
|
$88368.8
|
$-8.12
|
|
Revenue
|
$ .06M
|
$ M
|
$
|
Gross Profit
|
$ -.51M
|
$ M
|
$
|
Net Income / Loss
|
$ -26.1M
|
$ -5.95M
|
$
|
Operating Income / Loss
|
$ -21.94M
|
$ -5.61M
|
$
|
Cost of Revenue
|
$ .56M
|
$ M
|
$
|
Net Cash Flow
|
$ .74M
|
$ M
|
$
|
PE Ratio
|
0.00
|
|
|
Splits |
Mar 17, 2025:
1:250
|
Oct 02, 2024:
1:40
|
Aug 18, 2023:
1:40
|
Sep 14, 2022:
1:50
|
|
|
|